1. Home
  2. BLND vs BWAY Comparison

BLND vs BWAY Comparison

Compare BLND & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blend Labs Inc.

BLND

Blend Labs Inc.

HOLD

Current Price

$1.72

Market Cap

436.4M

Sector

Technology

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$24.06

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLND
BWAY
Founded
2012
2003
Country
United States
Israel
Employees
540
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
436.4M
450.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BLND
BWAY
Price
$1.72
$24.06
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
$4.80
$26.50
AVG Volume (30 Days)
3.3M
79.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
68.42
N/A
EPS
N/A
N/A
Revenue
$162,019,000.00
N/A
Revenue This Year
N/A
$314.08
Revenue Next Year
$19.81
$23.37
P/E Ratio
N/A
$81.98
Revenue Growth
3.30
N/A
52 Week Low
$1.57
$7.84
52 Week High
$4.49
$26.63

Technical Indicators

Market Signals
Indicator
BLND
BWAY
Relative Strength Index (RSI) 32.56 52.86
Support Level N/A $14.79
Resistance Level $3.73 $25.71
Average True Range (ATR) 0.12 1.39
MACD 0.03 -0.15
Stochastic Oscillator 28.72 35.03

Price Performance

Historical Comparison
BLND
BWAY

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: